20 results
Thumbnail

- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells

Thumbnail

- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib

Thumbnail

- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series

Thumbnail

- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis

Thumbnail

D3.288 - Evaluating the role of dust mite sensitization in the development of edible insect allergies

Thumbnail

D3.289 - Tolerance Assessment in Children with IgE-Mediated Cow's Milk Allergy Using Different Cutoff Values of Cow’s Milk Specific IgE

Thumbnail

D3.284 - Milk Aversion After Successful Desensitization in a Milk-Allergic Child

Thumbnail

D3.283 - Oat-Induced Anaphylaxis: Allergenic Characterization in a Clinical Case

Thumbnail

D3.286 - Infant feeding patterns, perinatal history and the development of food allergy in early childhood

Thumbnail

D3.287 - Tick Bite–Induced Alpha-Gal Syndrome: A Report of Two Cases and Literature Review Focusing on Clinical Characteristics of Asian Patients

Thumbnail

D3.291 - Molecular Identification of Heat-Stable β-Parvalbumin in megrim (Lepidorhombus boscii) as the Likely Allergen in a Child With Selective Fish Reactivity

Thumbnail

D3.292 - Safety profile of the yellow fever vaccine in egg-allergic children

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project

Thumbnail

D3.427 - Challenging the paradigm: Use of omalizumab in refractory angioedema in a 2-year-old child

Thumbnail

D3.428 - Substratification of Biologic Treatment Using Dupilumab in Eosinophilic COPD

Thumbnail

D3.417 - Dupilumab in pediatric patients with severe atopic dermatitis